E-GEOD-46899 - Cyclodextrin protects podocytes in diabetic kidney disease [HumanHT-12 V4.0 array]

Status
Released on 13 July 2013, last updated on 3 June 2014
Organism
Homo sapiens
Samples (6)
Array (1)
Protocols (7)
Description
Analysis of gene expression changes in differentiated human podocytes treated with the serum from patients with (DKD+) or without (DKD-) diabetic kidney disease when compared to normal subjects (C). The hypothesis is that the three groups can be distinghed by their differential gene expression pattern. The results obtained revealed important information regarding differences in gene expression in human podocytes treated with the serum from patients with (DKD+) or without (DKD-) diabetic kidney disease when compared to normal subjects (C). Human podocytes were contacted with the serum from patients with diabetes and kidney disease (DKD+) or without kidney disease (DKD-) and compared to normal human podocytes contacted with serum from patients without diabetes (C).
Experiment type
transcription profiling by array 
Contacts
Sandra Merscher-Gomez <smerscher@med.miami.edu>, Alessia Fornoni, Ann Randolph, Armando Mendez, Carol Forsblom, Christopher E Pedigo, Dony Maiguel, George W Burke III, Johanna Guzman, Kevin Johnson, Mariann I Lassenius, Markku Lehto, Matthias Kretzler, Per-Henrik Groop, Robert G Nelson, Robier Aguillon-Prada, Rodrigo Villarreal, Ronald Goldberg, TaeHyun Yoo, Viji Nair
MIAME
PlatformsProtocolsFactorsProcessedRaw
Files
Investigation descriptionE-GEOD-46899.idf.txt
Sample and data relationshipE-GEOD-46899.sdrf.txt
Processed data (1)E-GEOD-46899.processed.1.zip
Array designA-GEOD-10558.adf.txt
Links